Interventional Radiology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain.
Endocrinology, Hospital Universitario Fundacion Jiménez Diaz, Madrid, Spain.
Eur Thyroid J. 2023 Jan 25;12(1). doi: 10.1530/ETJ-22-0175. Print 2023 Feb 1.
This study aimed to evaluate the safety and long-term efficacy using the multiple overlapping ablation technique with a novel non-cooled microwave system in benign symptomatic thyroid nodules.
This prospective cohort single-center study collected complication data from the start of the procedure to 30 days postoperatively and evaluated the safety and effectiveness with a follow-up of 24 months. Ultrasound examinations were performed to determine the volume shrinkage during follow-up. Thyroid function cosmetic and symptoms scores and satisfaction degree were evaluated.
A total of 30 symptomatic benign thyroid nodules were treated by microwave ablation using a power between 15 and 30 W depending on the size of the nodule to be treated. The volume reduction rates in months 1, 3, 6, 9, 12, and 24 after ablation were 32, 59, 67, 69, 73, and 81%, respectively. The mean symptom score and mean cosmetic score before treatment were 4 and 3, respectively, while after treatment they dropped to 3 and 1, respectively. Thyroid function indicators fluctuated in the normal range and those with hyperthyroidism recovered to normal parameters. One case of temporary laryngeal paralysis occurred postoperatively and fully recovered in less than 3 months.
The novel microwave ablation system presented herein can help achieve good clinical success rate in benign thyroid nodules with a satisfying safety profile. The microwave ablation performed with the multiple overlapping ablation technique could be a good alternative to surgery and radiofrequency ablation in the management of benign thyroid nodules.
本研究旨在评估使用新型非冷冻微波系统进行多次重叠消融技术治疗良性症状性甲状腺结节的安全性和长期疗效。
本前瞻性队列单中心研究收集了从手术开始到术后 30 天的并发症数据,并在 24 个月的随访中评估了安全性和有效性。超声检查用于确定随访期间的体积缩小情况。评估甲状腺功能、美容和症状评分以及满意度。
共对 30 个有症状的良性甲状腺结节进行了微波消融治疗,根据要治疗的结节大小,功率在 15 至 30 W 之间。消融后 1、3、6、9、12 和 24 个月的体积缩小率分别为 32%、59%、67%、69%、73%和 81%。治疗前的平均症状评分和平均美容评分分别为 4 分和 3 分,治疗后分别降至 3 分和 1 分。甲状腺功能指标波动在正常范围内,甲状腺功能亢进症患者恢复到正常参数。术后出现 1 例暂时性喉麻痹,3 个月内完全恢复。
新型微波消融系统可帮助实现良性甲状腺结节的良好临床成功率,并具有良好的安全性。使用多次重叠消融技术进行微波消融可以成为良性甲状腺结节治疗的手术和射频消融的替代方法。